Searched for
SOFRAMYCIN
Encube Ethicals stake sale on hold, IPO likely by 2027Global private equity firms including Warburg Pincus, EQT, and Partners Group had shown interest in acquiring the business at $1.5-1.6 bill...- Warburg-Mubadala team up, emerge as frontrunner for EncubeThe consortium is competing against EQT. Mumbai-based pharma co likely to be valued at $1.8 bn. Binding bids are scheduled for next week.
- CORONA remedies buys Sanofi India's ortho brand MyorilAhmedabad-based pharmaceutical company CORONA Remedies has acquired the muscle relaxant brand Myoril from Sanofi India for Rs234 crore. The...
- When net profits grow faster than economy: 6 stocks with up to 41% upside potentialStocks that consistently beat the economy when it comes to growth, have the ability to generate above-average returns in the medium to long...
- Will PLI help Indian pharma gain market share at cost of MNCs?Indian pharmaceutical companies are becoming more aggressive and increasing their market share and capex. Companies such as Divis, Dr Reddy...
- Bayer's consumer health unit plans to step up India playIn an interview to ET, Sandeep Verma, country head, India, Bayer consumer health division in India, said the company will use its global ex...
- Encube Ethicals to buy Soframycin for Rs 125 crore for India & SL marketsEncube Ethicals has agreed to buy popular topical anti-microbial brand Soframycin and other brands from French drugmaker Sanofi for India a...
- Domestic growth may lift Q4 pharma marginsIndian pharmaceutical companies are expected to report brisk sales growth and improved margins for the quarter ended March 2008, cashing in...
Load More